Dana-Farber researchers find that immune booster combined with checkpoint blocker improves survival in metastatic melanoma

Researchers reported survival of patients with advanced melanoma was improved when they received an immune stimulant along with a checkpoint blocker immunotherapy drug. …read more

Source:: Cancer